Cellular activation insulin therapy

1. A method of treating a patient in need thereof, comprising:

establishing a pre-treatment blood sugar level in the patient of at least 250-300 mg/dL; and treating the patient with at least first and second cycles, each cycle comprising (1) pulsing a fast-acting insulin to the patient in a concentration of 10%+3% such that each of the first and second cycles targets to achieve a target intra-treatment blood sugar level (BSL) swing of more than 100 mg/dL, and (2) raising the blood sugar level to at least 250-300 mg/dL by administering carbohydrate.

2. The method of claim 1 , wherein the fast acting insulin comprises a recombinant human insulin.

3. The method of claim 2 , wherein the concentration of insulin being pulsed is 20% insulin±3%.

4. The method of claim 2 , wherein the concentration of insulin being pulsed is 30% insulin±3%.

5. The method of claim 2 , wherein the concentration of insulin being pulsed is 40% insulin±3%.

6. The method of claim 1 , wherein the target intra-treatment blood sugar level (BSL) swing of at least 125 mg/dL.

7. The method of claim 1 , wherein the target intra-treatment blood sugar level (BSL) swing of at least 150 mg/dL.

8. The method of claim 1 , wherein the step of raising the blood sugar level comprises administering sucrose to the patient.

9. The method of claim 1 , wherein the step of raising the blood sugar level comprises administering food to the patient.

10. The method of claim 1 , further comprising pulsing the insulin to the patient at irregular intervals.